DECIPHEX
Deciphex is an Irish-based software company focused on developing digital pathology-based solutions for clinical and research pathology. Our ambition is to deliver solutions that provide tangible productivity benefits to pathologists, eliminating low-level tasks so they can focus on the critical content. We believe that digital pathology combined with artificial intelligence will help make pathologists work more efficiently in the future, offering a solution to the pending challenges in supply/demand in pathology services. Deciphex plans to be at the forefront of this revolution with cleverly positioned solutions that deliver on the biggest problems facing pathology today.
DECIPHEX
Industry:
Artificial Intelligence Biotechnology Health Diagnostics Software
Founded:
2017-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.deciphex.com
Total Employee:
51+
Status:
Active
Total Funding:
20.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Rad AI
Rad AI focuses on automating radiology and health system processes.
Current Employees Featured
Mark Gregson CTO @ Deciphex
CTO
Trevor McKee Director of Commercial AI Services (Research Pathology) @ Deciphex
Director of Commercial AI Services (Research Pathology)
2022-02-01
Mairin Rafferty COO @ Deciphex
COO
2017-05-01
Donal O'Shea CEO @ Deciphex
CEO
Founder
Investors List
Charles River Laboratories International
Charles River Laboratories International investment in Series B - Deciphex
Novartis
Novartis investment in Series B - Deciphex
HBAN Medtech Syndicate
HBAN Medtech Syndicate investment in Series B - Deciphex
Act Venture Capital
Act Venture Capital investment in Series B - Deciphex
NextSteps Capital
NextSteps Capital investment in Series B - Deciphex
Irrus Investments
Irrus Investments investment in Series B - Deciphex
Act Venture Capital
Act Venture Capital investment in Series A - Deciphex
Irrus Investments
Irrus Investments investment in Series A - Deciphex
GI Partners
GI Partners investment in Series A - Deciphex
NextSteps Capital
NextSteps Capital investment in Series A - Deciphex
Official Site Inspections
http://www.deciphex.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Deciphex"
Deciphex - Crunchbase Company Profile & Funding
Founded in 2017, Deciphex aims to transform diagnostic workflows through AI-powered digital pathology to improve patient outcomes worldwide. Its two …See details»
Deciphex
With the world’s largest repository of digital slides, Deciphex is pioneering pathologist-centric foundation models. Rooted in clinical data and insights, our models redefine AI in pathology, …See details»
Deciphex - Accelerating Certainty
Deciphex is at the forefront of this revolution, networking and AI enabling Pathologists from all corners of the globe to drive high-quality, efficient reporting, enhancing patient care and …See details»
Deciphex - LinkedIn
Deciphex | 8,477 followers on LinkedIn. Transforming Pathology using Tailored Workflows and Artificial Intelligence | Deciphex is building a global network of AI empowered pathologists, ensuring ...See details»
Deciphex - moltenventures.com
Founded in 2017, Deciphex aims to transform diagnostic workflows through AI-powered digital pathology to improve patient outcomes worldwide. Its two flagship platforms target distinct …See details»
Deciphex - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Venture Round - Deciphex . …See details»
Deciphex raises £26m to expand pathology access
Jan 9, 2025 Deciphex announced in April 2023 that its UK digital pathology facility had expanded, tripling its capacity to meet the growing demand for digital pathology services. The Deciphex Exeter Accession Facility is the central hub …See details»
Portfolio spotlight: Donal O’Shea, CEO of Deciphex
Sep 3, 2024 Claret first invested in Deciphex, a CEGCF III portfolio company, in 2023, supporting the company’s mission as it continues to transform pathology through digital …See details»
Ireland’s Deciphex, AI pathology firm, raises $32m
Jan 13, 2025 “Deciphex’s platforms, Diagnexia and Patholytix, address this crisis through AI-powered digital pathology that enables pathologists to work up to 40% faster while maintaining …See details»
Deciphex raises €31m in new funding round to fuel …
Jan 7, 2025 Deciphex chief operating officer Mairin Rafferty with chief executive Donal O’Shea. It has raised $32.3 million (€31 million) from investors in a new funding round that will help fuel its ...See details»
Careers at Deciphex - Upgrade Yourself
Being part of the Deciphex Team really brings out the best in me, and inspires me every day to do my best to support my colleagues and our customers alike. careers at deciphex Work with us. …See details»
Business Corporation - North Carolina Secretary of State
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https ... Legal name: Deciphex Inc. …See details»
Deciphex Careers and Employment | Indeed.com
Deciphex is a fast growing organisation made up of talented professionals, all geared towards addressing the pathology productivity gap. Through our work, we help pharma accelerate the …See details»
Patholytix 4.0, Becomes First Platform To Support Future-proof …
May 30, 2024 Deciphex is a pioneering company at the forefront of the digital transformation of pathology. By networking with global pathologists and leveraging AI-driven solutions, Deciphex …See details»
Deciphex: $32.3 Million (Series C) Raised For Addressing The …
Jan 9, 2025 Deciphex, an AI-based digital pathology leader, announced it has closed its Series C funding at $32.3 million to address the acute global pathology crisis. Led by Molten Ventures …See details»
Charles River and Deciphex Extend Global Partnership to Expand …
WILMINGTON, Mass. and DUBLIN, Ireland—February 10, 2025—Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today …See details»
Diagnexia Announces Exeter Accession Facility Expansion with
Deciphex is an Irish-based software company focused on developing digital pathology-based software and services for clinical and research pathology. The company's aim is to network …See details»
Deciphex Xybion Micropathology LIMS | Tissuepathology.com
Sep 18, 2023 Deciphex is a pioneering company at the forefront of the digital transformation of pathology. By networking with global pathologists and leveraging AI-driven solutions, Deciphex …See details»
Deciphex and Xybion Digital join forces to Infuse the Power of ...
PRINCETON, NJ / ACCESSWIRE / September 14, 2023 / DUBLIN - Deciphex, a trailblazer in digitizing and networking global pathologists, has joined forces with Xybion, a global leader in …See details»